27.6 C
New York
Wednesday, June 3, 2026

Tag: science

/C O R R E C T I O N — Encoura/

In the news release, Encoura and Element451 Announce Strategic Partnership to Close Higher Ed's Gap Between Data Intelligence and Real-Time Action, issued 03-Jun-2026 by...

READY FOR LAUNCH: GOODYEAR HEADS BACK TO THE MOON

AKRON, Ohio, June 3, 2026 /PRNewswire/ -- Goodyear (NASDAQ: GT) takes on its next bold challenge, returning to the Moon with tires built for...

The $1 Billion Bet to Take Fusion Public

Issued on behalf of General Fusion Inc.VANCOUVER, BC, June 3, 2026 /PRNewswire/ -- Equity-Insider.com News Commentary — Fusion has been "thirty years away" for...

The $1 Billion Bet to Take Fusion Public

Issued on behalf of General Fusion Inc.VANCOUVER, BC, June 3, 2026 /CNW/ -- Equity-Insider.com News Commentary -- Fusion has been "thirty years away" for...

P2 Science Announces Appointment of Brian Chan as Chief Financial Officer

Seasoned finance executive brings deep experience scaling growth-stage companies and advancing strategic commercializationWOODBRIDGE, Conn., June 3, 2026 /PRNewswire/ -- P2 Science, Inc., a leading green...

ProBio and GCP ClinPlus Partner to Accelerate Clinical Trials in China

ProBio and GCP ClinPlus today announced a strategic collaboration designed to accelerate Investigator-Initiated Trials (IITs) in China and provide integrated, end-to-end clinical and development...

Slick City Action Park Names Josh Cole Chief Marketing Officer

Slick City names franchise marketing veteran Josh Cole as first CMO, tapping his growth expertise to accelerate expansion, support and brand awareness

The Expanding Frontier of Chemical Engineering: ChemE Show 2026 Opens June 9-10 in Houston

ExxonMobil, Eli Lilly, Johnson & Johnson, and Sinopec headline a two-day program where petrochemicals, pharma, and the energy transition convergeHOUSTON, June 3, 2026 /PRNewswire/...

New Anglia University: Is Spending Six Years Abroad Still the Best Route Into Medicine?

New Anglia University examines changing medical education pathways, including international medical education and NHS clinical experience.

Essity recognized on CDP Supplier Engagement A List for seventh consecutive year

STOCKHOLM, June 3, 2026 /PRNewswire/ -- Hygiene and health company Essity has once again been recognized for its leadership in sustainability by the global...

Essity recognized on CDP Supplier Engagement A List for seventh consecutive year

STOCKHOLM, June 3, 2026 /PRNewswire/ -- Hygiene and health company Essity has once again been recognized for its leadership in sustainability by the global...

Oceana Calls on Governments to Put Coastal Communities First at Our Ocean Conference in Kenya

Actor Kate Walsh to join Oceana in Mombasa at Our Ocean Conference to meet with local fishers and elevate coastal voices in global ocean decision making

JJP Biologics Announces Positive Interim Phase 1b Data for Nebaprubart (JJP-1212), an Anti-CD89 Antagonist, in Linear IgA Disease (LAD)

Warsaw, Poland – June 03, 2026 – JJP Biologics, ("JJPBio" or the "Company") a clinical-stage, immune-focused biotech that engineers precision antibodies to correct derailed immune pathways that drive autoimmune diseases and cancer, today announces positive interim data from its ongoing Phase 1b trial evaluating nebaprubart, also known as JJP-1212, its investigational potential first-in-class anti-CD89 antagonist, in patients diagnosed with Linear IgA Disease (LAD), a rare autoantibody-mediated skin disease.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsScience